Based in the United Kingdom, GW Pharmaceuticals was co-founded by Dr. Brian Whittle and Dr. Geoffrey Guy in 1988 (GW Pharmaceuticals, 2014) with the focuses of “discovering, developing and commercializing” medications which harness the therapeutic effects cannabis components for use in areas of oncology and Central Nervous System Disorders (GW Pharmaceuticals, 2014). GW’s lead product, Satives®, was the “world’s first plant derived cannabinoid prescription drug” with its main use being for the treatment of MS spasticity (GW Pharmaceuticals, 2014). The company is also developing Epidiolex® for the use of controlling pediatric epilepsy as well as researching many other avenues for product development (GW Pharmaceuticals, 2014). Since the initial public offering in 2013 on the NASDAQ Global Market, GW has rapidly grown and now the company “occupies a world leading position in cannabinoid science” (GW Pharmaceuticals, 2014). With patients as the driving force behind their efforts, …show more content…
GW Pharmaceuticals vision statement clearly outlines the positive way in which they intend to conduct themselves as a business where they are not only focused on profit but also the health and wellness of the consumer. Their main purpose is “to be the global leaders in prescription cannabinoid medicines, through the rapid cost-effective development of pharmaceutical products which address clear unmet needs” (GW Pharmaceuticals, 2014). Profit is key in any business as reflected by GW’s vision, but they also make it clear that they are invested in their consumers with their focus being to provide medications “which make a real difference to [the patients] quality of life” (GW Pharmaceuticals, 2014). Although GW does not have a distinct mission statement, they offer ways in
In the 19th century, the medical profession used cannabis preparations to treat multiple symptoms. Some including pain, convulsions, spasm, and nausea, and induce sleep (1). Soon, with the arrival of analgesics, came the decline in the medical use of cannabis. Therefore, cannabis was classified as
The management team at the over-the-counter cold medicine (OCM) group of Allstar Brands is looking to utilize revenue generated by Allround to help fund new opportunities in emerging markets. Therefore, it is critical that Allround maintain its market-leading position in terms of market share, profitability, and sales in order to fund these new initiatives.
Increasingly, more and more evidence shows how cannabidiol (CBD) cannabis is making a positive impact in treating children with rare diseases, particularly seizure conditions. The story of Jayden David, first shown on the Sanjay Gupta’s documentary Weed Wars, is only one of many that deserves to be told, as it highlights just how CBD oil is making a difference in the lives of families that dared to try their luck with an alternative form of treatment. CBD hemp oil, derived from the cannabis plant industrial hemp has been shown to alleviate a myriad of health conditions. Research and personal stories are expanding the dialogue on just how medical cannabis could be beneficial in treating conditions such as Dravet syndrome that plagues Jayden. CBD oil had made an incredible impact in Jayden’s life by reducing the frequency of his seizures and improving his quality of life.
The Pharmaceutical industry has been in the spotlight for decades due to the fact that they have a reputation for being unethical in its marketing strategies. In The Washington Post Shannon Brownlee (2008) states, “We try never to forget that medicine is for the people. It is not for the profits. The profits follow.” This honorable statement is completely lost in today’s world of pharmaceutical marketing tactics. These tactics are often deceptive and biased. Big Pharma consistently forgets their moral purpose and focuses primarily on the almighty dollar. Big Pharma is working on restoring their reputation by reforming their ethical code of conduct.
By this point in time, the opioid crisis is well-known and concerning. One potential solution suggested by researchers, medical professionals, and individual patients alike is the use of medical cannabis for treatment of conditions such as chronic pain. In fact, many patients now prefer medical cannabis to opioid treatments. It’s not difficult to see why.
New technologies have overcome some of these issues in targeted and controlled-release drug delivery and they are “vital for achieving increasing demands from doctors, patients, and payers” (Berger). Without maintaining standards, newly developed drugs take time to adjust to, but the issue is that the consumers won’t adjust their lifestyle or their budgets for them. Brave New World’s society and modern society are similar in this way due to the frequency of the consumption of drugs in order to ameliorate the mentalities of the consumers, but these consumers have a different outlook on what they’re taking. In modern society, individuals take the drugs that they think make them feel better whenever they desire to. If a person doesn’t feel well or they’re having a bad day, drugs, such as marijuana, come in handy to help fixate emotions to be positive and impact the mentalities within the consumer (Stripp).
In the United States, marijuana for medical purposes has gained more prevalence in current political discourse than in previous years. Marijuana, also known as cannabis, is a flowering plant that originally came from South and Central Asia. For centuries, the cannabis plant has been used for many natural products such as seed oils, seed, fiber that is used to make hemp products and contains over four hundred chemicals, some of which have an antibiotic like effect (Nordqvist, 2013). Studies have shown that two of the chemicals, tetrahydrocannabinol (THC) and Cannabidiol (CBD), have a positive effect on humans for mild to moderate painkilling effects and sedative effects (Nordqvist, 2013). The purpose of this paper is
The costs of capital and capital structures for Pfizer Inc. and its two competitors Merck & Co. Inc. and Johnson & Johnson in the pharmaceutical industry are analyzed in this memo.
Cannabis has provided millions worldwide with relief from chronic pain caused by a myriad of pain-producing illnesses. Cannabis has significantly improved the quality of life of people with cancer, AIDS, arthritis, and the list goes on. The medical marijuana movement is not concerned with decriminalizing or legalizing cannabis for recreational use. It is concerned with helping people with serious illnesses and disabilities to get on with their lives. (Bearman, 2011)
Marijuana is the most essential and therapeutically active substance that has been discovered by man. Therefore, medical cannabis refers to the use of the cannabis drug as recommended herbal therapy by physicians. This is mostly known as antiemetic. The experimental demonstration of marijuana’s significant properties thousands of years ago proves that it is one of the most essential substances that can be used in manufacturing drugs (Minamide). As provided from the ancient Indians, its psychoactive properties were realized which triggered its use by doctors to treat a variety of ailments and illnesses. This argument has been supported by the modern scientific experiment in the United States. Researchers have found that marijuana was greatly important in treatment of gastrointestinal disorders, headaches, pain reliever mostly in childbirth. In addition, they also found out that smoking marijuana reduces pain, especially with patients suffering from cancer, glaucoma, and chemotherapy (Minamide). In the recent past, marijuana has been found to be an important substance on AIDs patients where it reduces nausea, vomiting, and appetite loss. Moreover, it was recognized as a significant substance in relieving glaucoma eye pressure. It was also shown that it plays a vital role in Multiple Sclerosis. It reduces muscle pain, spasticity, and reduces diseases that cause body tremors. Epilepsy,
Medical marijuana has been proven to an effective drug in the treatment of a number of encumbering medical conditions. A large number of legitimate medical organizations recognize the benefits of marijuana. It is far less harmful and poses fewer negative side effects than many prescription drugs, including painkillers - and patients often find it to be a more effective treatment for a variety of illnesses. However, it is perhaps the most commonly misunderstood substance in America. The usage of the drug has been widely researched and proven to be a “most viable and safe source of medicine to many Americans suffering from Aids, Glaucoma, Cancer, Multiple Sclerosis, Epilepsy, and Chronic Pains” (Medical Marijuana). According to the Institute of Medicines, (1999) “marijuana, in its natural form, is one of the safest therapeutically active substances known” (Legalization of Marijuana). More and more resources and case studies will be further discussed and practices to back up the claim, and determine marijuana’s medical value.
Marijuana has been known to have medical benefits since long ago. It is tested and proven to be efficient in the treatment of various ailments. It has therapeutic effects and has been used since 1965 as a medicine (Syrakic et al. 92). The medicinal component of marijuana is known as cannabinoids and it was initially extracted and purified in 1965 (Syrakic et al. 92). Since then, more than four hundred chemicals have been extracted from marijuana (Syrakic et al. 92). This justifies the medical significance of the drug. It is used expansively to treat various ailments. Dronabinol, for example, is an extract from marijuana and a certified antiemetic for cancer patients undergoing chemotherapy (Syrakic et al. 92). It also stimulates the appetite in patients suffering from AIDS (Syrakic et al. 92). AIDS and cancer are terminal illnesses that lead to several deaths all over the world. In forming part of the medicine that can be used in mitigating the effects of these diseases, marijuana shows its contribution to the medical industry. Another extract that has proved useful in the medical field is sativex. Sativex contains 9-tetrahydrocannabinol (THC) and cannabidiol both of which have significant contributions in the
The use of cannabis toward medicine should not be shocking to anyone, since it has been around for centuries. As a matter of fact, it has been under medicinal aid for an estimated 5,000 years. Western medicine truly grasped marijuana’s medicinal abilities in the 1850’s. Infact, doctors documented over one hundred papers about how marijuana helped numerous disorders, such as nausea, glaucoma, movement disorders, pain relief, depression, and anxiety. It also helps cancer patients and those with HIV or Aids. Currently, many American patients have access to marijuana use so that they can have effective treatments for their illnesses. Medical marijuana use is achievable because
In 2005, Phillip (Phil) Landgraf faced several glaring problems in the financial performance of his company, BioPharma, Inc. The firm had experienced a steep decline in profits and very high costs at its plants in Germany and Japan. Landgraf, the company 's president for worldwide operations, knew that demand for the company 's products was stable across the globe. As a result, the surplus capacity in his global production network looked like a luxury he could no longer afford.
The first use of the synthetic cannabinoid substances appeared in several European countries around 2004 as a legal recreation and relaxation products alternatives to smoking marijuana [18, 19]. Two years later, these drugs were being sold predominantly on the internet and in some open markets such as the local smoke shops, and gas stations under brand name “Spice” and “K”[19], these two names have persisted as the generic term for all synthetic